In recent trading session, Alzamend Neuro Inc (NASDAQ:ALZN) saw 0.58 million shares changing hands at last check today with its beta currently measuring -0.09. Company’s recent per share price level of $1.19 trading at -$0.06 or -4.80% at last check today assigns it a market valuation of $6.46M. That most recent trading price of ALZN’s stock is at a discount of -1165.55% from its 52-week high price of $15.06 and is indicating a premium of 10.92% from its 52-week low price of $1.06. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 209.63K if we extend that period to 3-months.
For Alzamend Neuro Inc (ALZN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.29 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Alzamend Neuro Inc (NASDAQ:ALZN) trade information
Alzamend Neuro Inc’s shares saw a change of -86.63% in year-to-date performance and have moved 0.00% in past 5-day. Alzamend Neuro Inc (NASDAQ:ALZN) showed a performance of -9.16% in past 30-days. Number of shares sold short was 0.13 million shares which calculate 1.03 days to cover the short interests.
Alzamend Neuro Inc (ALZN) estimates and forecasts
Statistics highlight that Alzamend Neuro Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -69.45% of value to its shares in past 6 months, showing an annual growth rate of 2.93% while that of industry is 17.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -11.45% during past 5 years.
Alzamend Neuro Inc (NASDAQ:ALZN)’s Major holders
Insiders are in possession of 4.55% of company’s total shares while institution are holding 0.94 percent of that, with stock having share float percentage of 0.99%. Investors also watch the number of corporate investors in a company very closely, which is 0.94% institutions for Alzamend Neuro Inc that are currently holding shares of the company.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 7.85 shares of worth $9267.0 or 0.14% of the total outstanding shares. The later fund manager was in possession of 3.85 shares on Oct 31, 2024, making its stake of worth around $4540.0 in the company or a holder of 0.07% of company’s stock.
